Mouse IFN-γ T cell ELISPOT kit - 5-plate

SKU
CT317-B5
Complete ELISPOT kit including all reagents (480 determinations).
Format
5-plate
Price
€ 670
Documentation
Data sheet
Manual
SDS
Reactivity
Mouse
Category
T cell ELISPOT
Analyte
IFN-γ
Description
Our ELISPOT kits provide a complete, ready-to-use solution for reliable, high-performance ELISPOT assay. Each kit includes all essential components: coating and detection antibodies, streptavidin-HRP, TMB substrate, blocking stock solution, dilution buffer, and Tween-20.
Description
IFN-γ is a potent immune regulating cytokine that plays a central role in activating the body’s defense against infections and malignant cells. By enhancing antigen presentation and boosting the activity of T cells and natural killer (NK) cells, IFN-γ drives strong antiviral and anti tumor responses. It is primarily produced by activated T helper 1 (Th1) cells, cytotoxic T cells, γδ T cells, NK cells, and natural killer T (NKT) cells, making it a key indicator of cellular immune activation in research and diagnostic applications.
Alternative names
IFN-γ, IFN-gamma, IFN-g, IFNg, interferon γ, interferon-γ, interferon-gamma, interferon gamma, INF-g, INF-gamma, immune interferon, Type II interferon
Gene ID
15978
Related Products
CT317-B2 - Mouse IFN-γ T cell ELISPOT kit - 2-plate

References

Authors, et al. Title Journal Year Volume Pages
Laicheng Liu Differential Immune Responses and Protective Effects in Avirulent Mycobacterial Strains Vaccinated BALB/c Mice Curr Microbiol 2015 71 129-35
Hao Liu N-Linked Glycosylation at an Appropriate Position in the Pre-S2 Domain Is Critical for Cellular and Humoral Immunity against Middle HBV Surface Antigen Tohoku J Exp Med 2015 236 131-8
Zhi-Liang Duan Identification of Mycobacterium tuberculosis PPE68-specific HLA-A*0201-restricted epitopes for tuberculosis diagnosis Curr Microbiol 2015 70 769-78
Sheida Shariat Preparation and characterization of different liposomal formulations containing P5 HER2/neu-derived peptide and evaluation of their immunological responses and antitumor effects Iran J Basic Med Sci 2015 18 506-13
Meng Xu Intratumoral Delivery of IL-21 Overcomes Anti-Her2/Neu Resistance through Shifting Tumor-Associated Macrophages from M2 to M1 Phenotype J Immunol 2015 194 4997-5006
Shujie Liao A novel "priming-boosting" strategy for immune interventions in cervical cancer Mol Immunol 2015 64 295-305
Peter Soema Influenza T-cell epitope-loaded virosomes adjuvanted with CpG as a potential influenza vaccine Pharm Res 2015 32 1505-15
Yannick Fuchs Vagaries of the ELISpot assay: specific detection of antigen responsive cells requires purified CD8(+) T cells and MHC class I expressing antigen presenting cell lines Clin Immunol 2015 157 216-25
Yuhua Li Generation of cytotoxic T lymphocytes specific for native or modified peptides derived from the epidermal growth factor receptor pathway substrate 8 antigen Cancer Immunol Immunother 2015 64 259-69
Zhi-Liang Duan Identification of conserved and HLA-A*2402-restricted epitopes in Dengue virus serotype 2 Virus Res 2015 196 5-12